IRONWOOD PHARMACEUTICALS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.3 | $0.4 | $0.4 | $0.4 | $0.4 |
| Operating income | $0.1 | $0.1 | -$0.9 | $0.3 | $0.2 |
| Net income | $<0.1 | $<0.1 | -$1.0 | $0.2 | $0.5 |
| Balance Sheet | |||||
| Total debt | — | — | — | $0.4 | $0.5 |
| Cash Flow Statement | |||||
| Free cash flow | $0.1 | $0.1 | $0.2 | $0.3 | $0.3 |
| Share repurchases | — | — | $0.1 | $0.1 | $<0.1 |
Shares outstanding 165.2M · Free float 85.2%
Annual filing data through FY ended December 31, 2025; float as of September 29, 2026.